Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2, 2003. The report serves as a disclosure of changes in directors' interests in the company's Ordinary Shares rather than a comprehensive financial statement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The material changes reported relate exclusively to the transfer of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham 1991 Plan. The specific transactions are as follows:
- April 28, 2003: Transfer of 41,220 Ordinary Shares.
- April 29, 2003: Transfer of 51,346 Ordinary Shares.
- April 30, 2003: Transfer of 1,611 Ordinary Shares.
The Company was advised of these transactions on May 2, 2003.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Consequently, two directors, Dr J-P Garnier and Mr J D Coombe, hold an interest in the shares held within the GSK Trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares transferred from the GSK Trust to the SmithKline Beecham 1991 Plan participants (Total: 94,177 shares).
- Confirm the specific dates of the share transfers (April 28, 29, and 30, 2003).
- Review the full annual report (Form 20-F) for comprehensive financial metrics, as this filing does not contain them.